Global Cell and Gene Therapy Manufacturing Services Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 123

Published Date: 03 Jan 2023

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Gene therapy aims to treat disorders by replacing or introducing genes into cells— either inside the body (in vivo) or outside of the body (ex vivo).

According to our (Global Info Research) latest study, the global Cell and Gene Therapy Manufacturing Services market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Cell and Gene Therapy Manufacturing Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Cell and Gene Therapy Manufacturing Services market size and forecasts, in consumption value ($ Million), 2018-2029
Global Cell and Gene Therapy Manufacturing Services market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Cell and Gene Therapy Manufacturing Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Cell and Gene Therapy Manufacturing Services market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cell and Gene Therapy Manufacturing Services
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cell and Gene Therapy Manufacturing Services market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Merck KGaA, Charles River Laboratories, Lonza and Catalent, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Cell and Gene Therapy Manufacturing Services market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    By Cell Therapy
        Allogeneic
        Autologous
        Viral Vector
    By Gene Therapy
        Non-viral Vector
        Oligonucleotides
        Viral Vector

Market segment by Application
    Oncology Diseases
    Cardiovascular Diseases
    Orthopedic Diseases
    Ophthalmology Diseases
    Infectious Diseases
    Others

Market segment by players, this report covers
    Thermo Fisher Scientific
    Merck KGaA
    Charles River Laboratories
    Lonza
    Catalent
    WuXi AppTec
    Takara Bio Inc
    Nikon Corporation
    FUJIFILM Holdings Corporation
    F. Hoffmann-La Roche
    Oxford Biomedica Plc
    Cell and Gene Therapy Catapult
    The Discovery Labs LLC
    RoslinCT
    JRS PHARMA
    FinVector
    ABL
    Resilience
    BioCentriq
    Porton Biopharma Limited
    Andelyn Biosciences
    Commercializing Living Therapies
    Vibalogics
    Anemocyte Srl
    ElevateBio

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cell and Gene Therapy Manufacturing Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cell and Gene Therapy Manufacturing Services, with revenue, gross margin and global market share of Cell and Gene Therapy Manufacturing Services from 2018 to 2023.
Chapter 3, the Cell and Gene Therapy Manufacturing Services competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Cell and Gene Therapy Manufacturing Services market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Cell and Gene Therapy Manufacturing Services.
Chapter 13, to describe Cell and Gene Therapy Manufacturing Services research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Cell and Gene Therapy Manufacturing Services
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Cell and Gene Therapy Manufacturing Services by Type
        1.3.1 Overview: Global Cell and Gene Therapy Manufacturing Services Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Cell and Gene Therapy Manufacturing Services Consumption Value Market Share by Type in 2022
        1.3.3 Allogeneic
        1.3.4 Autologous
        1.3.5 Viral Vector
    1.4 Global Cell and Gene Therapy Manufacturing Services Market by Application
        1.4.1 Overview: Global Cell and Gene Therapy Manufacturing Services Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Oncology Diseases
        1.4.3 Cardiovascular Diseases
        1.4.4 Orthopedic Diseases
        1.4.5 Ophthalmology Diseases
        1.4.6 Infectious Diseases
        1.4.7 Others
    1.5 Global Cell and Gene Therapy Manufacturing Services Market Size & Forecast
    1.6 Global Cell and Gene Therapy Manufacturing Services Market Size and Forecast by Region
        1.6.1 Global Cell and Gene Therapy Manufacturing Services Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Cell and Gene Therapy Manufacturing Services Market Size by Region, (2018-2029)
        1.6.3 North America Cell and Gene Therapy Manufacturing Services Market Size and Prospect (2018-2029)
        1.6.4 Europe Cell and Gene Therapy Manufacturing Services Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size and Prospect (2018-2029)
        1.6.6 South America Cell and Gene Therapy Manufacturing Services Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Cell and Gene Therapy Manufacturing Services Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Thermo Fisher Scientific
        2.1.1 Thermo Fisher Scientific Details
        2.1.2 Thermo Fisher Scientific Major Business
        2.1.3 Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Product and Solutions
        2.1.4 Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
    2.2 Merck KGaA
        2.2.1 Merck KGaA Details
        2.2.2 Merck KGaA Major Business
        2.2.3 Merck KGaA Cell and Gene Therapy Manufacturing Services Product and Solutions
        2.2.4 Merck KGaA Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Merck KGaA Recent Developments and Future Plans
    2.3 Charles River Laboratories
        2.3.1 Charles River Laboratories Details
        2.3.2 Charles River Laboratories Major Business
        2.3.3 Charles River Laboratories Cell and Gene Therapy Manufacturing Services Product and Solutions
        2.3.4 Charles River Laboratories Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Charles River Laboratories Recent Developments and Future Plans
    2.4 Lonza
        2.4.1 Lonza Details
        2.4.2 Lonza Major Business
        2.4.3 Lonza Cell and Gene Therapy Manufacturing Services Product and Solutions
        2.4.4 Lonza Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Lonza Recent Developments and Future Plans
    2.5 Catalent
        2.5.1 Catalent Details
        2.5.2 Catalent Major Business
        2.5.3 Catalent Cell and Gene Therapy Manufacturing Services Product and Solutions
        2.5.4 Catalent Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Catalent Recent Developments and Future Plans
    2.6 WuXi AppTec
        2.6.1 WuXi AppTec Details
        2.6.2 WuXi AppTec Major Business
        2.6.3 WuXi AppTec Cell and Gene Therapy Manufacturing Services Product and Solutions
        2.6.4 WuXi AppTec Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 WuXi AppTec Recent Developments and Future Plans
    2.7 Takara Bio Inc
        2.7.1 Takara Bio Inc Details
        2.7.2 Takara Bio Inc Major Business
        2.7.3 Takara Bio Inc Cell and Gene Therapy Manufacturing Services Product and Solutions
        2.7.4 Takara Bio Inc Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Takara Bio Inc Recent Developments and Future Plans
    2.8 Nikon Corporation
        2.8.1 Nikon Corporation Details
        2.8.2 Nikon Corporation Major Business
        2.8.3 Nikon Corporation Cell and Gene Therapy Manufacturing Services Product and Solutions
        2.8.4 Nikon Corporation Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Nikon Corporation Recent Developments and Future Plans
    2.9 FUJIFILM Holdings Corporation
        2.9.1 FUJIFILM Holdings Corporation Details
        2.9.2 FUJIFILM Holdings Corporation Major Business
        2.9.3 FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Product and Solutions
        2.9.4 FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 FUJIFILM Holdings Corporation Recent Developments and Future Plans
    2.10 F. Hoffmann-La Roche
        2.10.1 F. Hoffmann-La Roche Details
        2.10.2 F. Hoffmann-La Roche Major Business
        2.10.3 F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Product and Solutions
        2.10.4 F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 F. Hoffmann-La Roche Recent Developments and Future Plans
    2.11 Oxford Biomedica Plc
        2.11.1 Oxford Biomedica Plc Details
        2.11.2 Oxford Biomedica Plc Major Business
        2.11.3 Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Product and Solutions
        2.11.4 Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Oxford Biomedica Plc Recent Developments and Future Plans
    2.12 Cell and Gene Therapy Catapult
        2.12.1 Cell and Gene Therapy Catapult Details
        2.12.2 Cell and Gene Therapy Catapult Major Business
        2.12.3 Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Product and Solutions
        2.12.4 Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Cell and Gene Therapy Catapult Recent Developments and Future Plans
    2.13 The Discovery Labs LLC
        2.13.1 The Discovery Labs LLC Details
        2.13.2 The Discovery Labs LLC Major Business
        2.13.3 The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Product and Solutions
        2.13.4 The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 The Discovery Labs LLC Recent Developments and Future Plans
    2.14 RoslinCT
        2.14.1 RoslinCT Details
        2.14.2 RoslinCT Major Business
        2.14.3 RoslinCT Cell and Gene Therapy Manufacturing Services Product and Solutions
        2.14.4 RoslinCT Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 RoslinCT Recent Developments and Future Plans
    2.15 JRS PHARMA
        2.15.1 JRS PHARMA Details
        2.15.2 JRS PHARMA Major Business
        2.15.3 JRS PHARMA Cell and Gene Therapy Manufacturing Services Product and Solutions
        2.15.4 JRS PHARMA Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        2.15.5 JRS PHARMA Recent Developments and Future Plans
    2.16 FinVector
        2.16.1 FinVector Details
        2.16.2 FinVector Major Business
        2.16.3 FinVector Cell and Gene Therapy Manufacturing Services Product and Solutions
        2.16.4 FinVector Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        2.16.5 FinVector Recent Developments and Future Plans
    2.17 ABL
        2.17.1 ABL Details
        2.17.2 ABL Major Business
        2.17.3 ABL Cell and Gene Therapy Manufacturing Services Product and Solutions
        2.17.4 ABL Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        2.17.5 ABL Recent Developments and Future Plans
    2.18 Resilience
        2.18.1 Resilience Details
        2.18.2 Resilience Major Business
        2.18.3 Resilience Cell and Gene Therapy Manufacturing Services Product and Solutions
        2.18.4 Resilience Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        2.18.5 Resilience Recent Developments and Future Plans
    2.19 BioCentriq
        2.19.1 BioCentriq Details
        2.19.2 BioCentriq Major Business
        2.19.3 BioCentriq Cell and Gene Therapy Manufacturing Services Product and Solutions
        2.19.4 BioCentriq Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        2.19.5 BioCentriq Recent Developments and Future Plans
    2.20 Porton Biopharma Limited
        2.20.1 Porton Biopharma Limited Details
        2.20.2 Porton Biopharma Limited Major Business
        2.20.3 Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Product and Solutions
        2.20.4 Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        2.20.5 Porton Biopharma Limited Recent Developments and Future Plans
    2.21 Andelyn Biosciences
        2.21.1 Andelyn Biosciences Details
        2.21.2 Andelyn Biosciences Major Business
        2.21.3 Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Product and Solutions
        2.21.4 Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        2.21.5 Andelyn Biosciences Recent Developments and Future Plans
    2.22 Commercializing Living Therapies
        2.22.1 Commercializing Living Therapies Details
        2.22.2 Commercializing Living Therapies Major Business
        2.22.3 Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Product and Solutions
        2.22.4 Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        2.22.5 Commercializing Living Therapies Recent Developments and Future Plans
    2.23 Vibalogics
        2.23.1 Vibalogics Details
        2.23.2 Vibalogics Major Business
        2.23.3 Vibalogics Cell and Gene Therapy Manufacturing Services Product and Solutions
        2.23.4 Vibalogics Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        2.23.5 Vibalogics Recent Developments and Future Plans
    2.24 Anemocyte Srl
        2.24.1 Anemocyte Srl Details
        2.24.2 Anemocyte Srl Major Business
        2.24.3 Anemocyte Srl Cell and Gene Therapy Manufacturing Services Product and Solutions
        2.24.4 Anemocyte Srl Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        2.24.5 Anemocyte Srl Recent Developments and Future Plans
    2.25 ElevateBio
        2.25.1 ElevateBio Details
        2.25.2 ElevateBio Major Business
        2.25.3 ElevateBio Cell and Gene Therapy Manufacturing Services Product and Solutions
        2.25.4 ElevateBio Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        2.25.5 ElevateBio Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Cell and Gene Therapy Manufacturing Services Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Cell and Gene Therapy Manufacturing Services by Company Revenue
        3.2.2 Top 3 Cell and Gene Therapy Manufacturing Services Players Market Share in 2022
        3.2.3 Top 6 Cell and Gene Therapy Manufacturing Services Players Market Share in 2022
    3.3 Cell and Gene Therapy Manufacturing Services Market: Overall Company Footprint Analysis
        3.3.1 Cell and Gene Therapy Manufacturing Services Market: Region Footprint
        3.3.2 Cell and Gene Therapy Manufacturing Services Market: Company Product Type Footprint
        3.3.3 Cell and Gene Therapy Manufacturing Services Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Cell and Gene Therapy Manufacturing Services Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Cell and Gene Therapy Manufacturing Services Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Cell and Gene Therapy Manufacturing Services Consumption Value Market Share by Application (2018-2023)
    5.2 Global Cell and Gene Therapy Manufacturing Services Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Cell and Gene Therapy Manufacturing Services Consumption Value by Type (2018-2029)
    6.2 North America Cell and Gene Therapy Manufacturing Services Consumption Value by Application (2018-2029)
    6.3 North America Cell and Gene Therapy Manufacturing Services Market Size by Country
        6.3.1 North America Cell and Gene Therapy Manufacturing Services Consumption Value by Country (2018-2029)
        6.3.2 United States Cell and Gene Therapy Manufacturing Services Market Size and Forecast (2018-2029)
        6.3.3 Canada Cell and Gene Therapy Manufacturing Services Market Size and Forecast (2018-2029)
        6.3.4 Mexico Cell and Gene Therapy Manufacturing Services Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Cell and Gene Therapy Manufacturing Services Consumption Value by Type (2018-2029)
    7.2 Europe Cell and Gene Therapy Manufacturing Services Consumption Value by Application (2018-2029)
    7.3 Europe Cell and Gene Therapy Manufacturing Services Market Size by Country
        7.3.1 Europe Cell and Gene Therapy Manufacturing Services Consumption Value by Country (2018-2029)
        7.3.2 Germany Cell and Gene Therapy Manufacturing Services Market Size and Forecast (2018-2029)
        7.3.3 France Cell and Gene Therapy Manufacturing Services Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Cell and Gene Therapy Manufacturing Services Market Size and Forecast (2018-2029)
        7.3.5 Russia Cell and Gene Therapy Manufacturing Services Market Size and Forecast (2018-2029)
        7.3.6 Italy Cell and Gene Therapy Manufacturing Services Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Cell and Gene Therapy Manufacturing Services Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Cell and Gene Therapy Manufacturing Services Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size by Region
        8.3.1 Asia-Pacific Cell and Gene Therapy Manufacturing Services Consumption Value by Region (2018-2029)
        8.3.2 China Cell and Gene Therapy Manufacturing Services Market Size and Forecast (2018-2029)
        8.3.3 Japan Cell and Gene Therapy Manufacturing Services Market Size and Forecast (2018-2029)
        8.3.4 South Korea Cell and Gene Therapy Manufacturing Services Market Size and Forecast (2018-2029)
        8.3.5 India Cell and Gene Therapy Manufacturing Services Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Cell and Gene Therapy Manufacturing Services Market Size and Forecast (2018-2029)
        8.3.7 Australia Cell and Gene Therapy Manufacturing Services Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Cell and Gene Therapy Manufacturing Services Consumption Value by Type (2018-2029)
    9.2 South America Cell and Gene Therapy Manufacturing Services Consumption Value by Application (2018-2029)
    9.3 South America Cell and Gene Therapy Manufacturing Services Market Size by Country
        9.3.1 South America Cell and Gene Therapy Manufacturing Services Consumption Value by Country (2018-2029)
        9.3.2 Brazil Cell and Gene Therapy Manufacturing Services Market Size and Forecast (2018-2029)
        9.3.3 Argentina Cell and Gene Therapy Manufacturing Services Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Cell and Gene Therapy Manufacturing Services Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Cell and Gene Therapy Manufacturing Services Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Country
        10.3.1 Middle East & Africa Cell and Gene Therapy Manufacturing Services Consumption Value by Country (2018-2029)
        10.3.2 Turkey Cell and Gene Therapy Manufacturing Services Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Cell and Gene Therapy Manufacturing Services Market Size and Forecast (2018-2029)
        10.3.4 UAE Cell and Gene Therapy Manufacturing Services Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Cell and Gene Therapy Manufacturing Services Market Drivers
    11.2 Cell and Gene Therapy Manufacturing Services Market Restraints
    11.3 Cell and Gene Therapy Manufacturing Services Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Cell and Gene Therapy Manufacturing Services Industry Chain
    12.2 Cell and Gene Therapy Manufacturing Services Upstream Analysis
    12.3 Cell and Gene Therapy Manufacturing Services Midstream Analysis
    12.4 Cell and Gene Therapy Manufacturing Services Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Cell and Gene Therapy Manufacturing Services Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Cell and Gene Therapy Manufacturing Services Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Cell and Gene Therapy Manufacturing Services Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Cell and Gene Therapy Manufacturing Services Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
    Table 6. Thermo Fisher Scientific Major Business
    Table 7. Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Product and Solutions
    Table 8. Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Thermo Fisher Scientific Recent Developments and Future Plans
    Table 10. Merck KGaA Company Information, Head Office, and Major Competitors
    Table 11. Merck KGaA Major Business
    Table 12. Merck KGaA Cell and Gene Therapy Manufacturing Services Product and Solutions
    Table 13. Merck KGaA Cell and Gene Therapy Manufacturing Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Merck KGaA Recent Developments and Future Plans
    Table 15. Charles River Laboratories Company Information, Head Office, and Major Competitors
    Table 16. Charles River Laboratories Major Business
    Table 17. Charles River Laboratories Cell and Gene Therapy Manufacturing Services Product and Solutions
    Table 18. Charles River Laboratories Cell and Gene Therapy Manufacturing Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Charles River Laboratories Recent Developments and Future Plans
    Table 20. Lonza Company Information, Head Office, and Major Competitors
    Table 21. Lonza Major Business
    Table 22. Lonza Cell and Gene Therapy Manufacturing Services Product and Solutions
    Table 23. Lonza Cell and Gene Therapy Manufacturing Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Lonza Recent Developments and Future Plans
    Table 25. Catalent Company Information, Head Office, and Major Competitors
    Table 26. Catalent Major Business
    Table 27. Catalent Cell and Gene Therapy Manufacturing Services Product and Solutions
    Table 28. Catalent Cell and Gene Therapy Manufacturing Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Catalent Recent Developments and Future Plans
    Table 30. WuXi AppTec Company Information, Head Office, and Major Competitors
    Table 31. WuXi AppTec Major Business
    Table 32. WuXi AppTec Cell and Gene Therapy Manufacturing Services Product and Solutions
    Table 33. WuXi AppTec Cell and Gene Therapy Manufacturing Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. WuXi AppTec Recent Developments and Future Plans
    Table 35. Takara Bio Inc Company Information, Head Office, and Major Competitors
    Table 36. Takara Bio Inc Major Business
    Table 37. Takara Bio Inc Cell and Gene Therapy Manufacturing Services Product and Solutions
    Table 38. Takara Bio Inc Cell and Gene Therapy Manufacturing Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Takara Bio Inc Recent Developments and Future Plans
    Table 40. Nikon Corporation Company Information, Head Office, and Major Competitors
    Table 41. Nikon Corporation Major Business
    Table 42. Nikon Corporation Cell and Gene Therapy Manufacturing Services Product and Solutions
    Table 43. Nikon Corporation Cell and Gene Therapy Manufacturing Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. Nikon Corporation Recent Developments and Future Plans
    Table 45. FUJIFILM Holdings Corporation Company Information, Head Office, and Major Competitors
    Table 46. FUJIFILM Holdings Corporation Major Business
    Table 47. FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Product and Solutions
    Table 48. FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. FUJIFILM Holdings Corporation Recent Developments and Future Plans
    Table 50. F. Hoffmann-La Roche Company Information, Head Office, and Major Competitors
    Table 51. F. Hoffmann-La Roche Major Business
    Table 52. F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Product and Solutions
    Table 53. F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. F. Hoffmann-La Roche Recent Developments and Future Plans
    Table 55. Oxford Biomedica Plc Company Information, Head Office, and Major Competitors
    Table 56. Oxford Biomedica Plc Major Business
    Table 57. Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Product and Solutions
    Table 58. Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 59. Oxford Biomedica Plc Recent Developments and Future Plans
    Table 60. Cell and Gene Therapy Catapult Company Information, Head Office, and Major Competitors
    Table 61. Cell and Gene Therapy Catapult Major Business
    Table 62. Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Product and Solutions
    Table 63. Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 64. Cell and Gene Therapy Catapult Recent Developments and Future Plans
    Table 65. The Discovery Labs LLC Company Information, Head Office, and Major Competitors
    Table 66. The Discovery Labs LLC Major Business
    Table 67. The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Product and Solutions
    Table 68. The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 69. The Discovery Labs LLC Recent Developments and Future Plans
    Table 70. RoslinCT Company Information, Head Office, and Major Competitors
    Table 71. RoslinCT Major Business
    Table 72. RoslinCT Cell and Gene Therapy Manufacturing Services Product and Solutions
    Table 73. RoslinCT Cell and Gene Therapy Manufacturing Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 74. RoslinCT Recent Developments and Future Plans
    Table 75. JRS PHARMA Company Information, Head Office, and Major Competitors
    Table 76. JRS PHARMA Major Business
    Table 77. JRS PHARMA Cell and Gene Therapy Manufacturing Services Product and Solutions
    Table 78. JRS PHARMA Cell and Gene Therapy Manufacturing Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 79. JRS PHARMA Recent Developments and Future Plans
    Table 80. FinVector Company Information, Head Office, and Major Competitors
    Table 81. FinVector Major Business
    Table 82. FinVector Cell and Gene Therapy Manufacturing Services Product and Solutions
    Table 83. FinVector Cell and Gene Therapy Manufacturing Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 84. FinVector Recent Developments and Future Plans
    Table 85. ABL Company Information, Head Office, and Major Competitors
    Table 86. ABL Major Business
    Table 87. ABL Cell and Gene Therapy Manufacturing Services Product and Solutions
    Table 88. ABL Cell and Gene Therapy Manufacturing Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. ABL Recent Developments and Future Plans
    Table 90. Resilience Company Information, Head Office, and Major Competitors
    Table 91. Resilience Major Business
    Table 92. Resilience Cell and Gene Therapy Manufacturing Services Product and Solutions
    Table 93. Resilience Cell and Gene Therapy Manufacturing Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 94. Resilience Recent Developments and Future Plans
    Table 95. BioCentriq Company Information, Head Office, and Major Competitors
    Table 96. BioCentriq Major Business
    Table 97. BioCentriq Cell and Gene Therapy Manufacturing Services Product and Solutions
    Table 98. BioCentriq Cell and Gene Therapy Manufacturing Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 99. BioCentriq Recent Developments and Future Plans
    Table 100. Porton Biopharma Limited Company Information, Head Office, and Major Competitors
    Table 101. Porton Biopharma Limited Major Business
    Table 102. Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Product and Solutions
    Table 103. Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 104. Porton Biopharma Limited Recent Developments and Future Plans
    Table 105. Andelyn Biosciences Company Information, Head Office, and Major Competitors
    Table 106. Andelyn Biosciences Major Business
    Table 107. Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Product and Solutions
    Table 108. Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 109. Andelyn Biosciences Recent Developments and Future Plans
    Table 110. Commercializing Living Therapies Company Information, Head Office, and Major Competitors
    Table 111. Commercializing Living Therapies Major Business
    Table 112. Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Product and Solutions
    Table 113. Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 114. Commercializing Living Therapies Recent Developments and Future Plans
    Table 115. Vibalogics Company Information, Head Office, and Major Competitors
    Table 116. Vibalogics Major Business
    Table 117. Vibalogics Cell and Gene Therapy Manufacturing Services Product and Solutions
    Table 118. Vibalogics Cell and Gene Therapy Manufacturing Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. Vibalogics Recent Developments and Future Plans
    Table 120. Anemocyte Srl Company Information, Head Office, and Major Competitors
    Table 121. Anemocyte Srl Major Business
    Table 122. Anemocyte Srl Cell and Gene Therapy Manufacturing Services Product and Solutions
    Table 123. Anemocyte Srl Cell and Gene Therapy Manufacturing Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 124. Anemocyte Srl Recent Developments and Future Plans
    Table 125. ElevateBio Company Information, Head Office, and Major Competitors
    Table 126. ElevateBio Major Business
    Table 127. ElevateBio Cell and Gene Therapy Manufacturing Services Product and Solutions
    Table 128. ElevateBio Cell and Gene Therapy Manufacturing Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 129. ElevateBio Recent Developments and Future Plans
    Table 130. Global Cell and Gene Therapy Manufacturing Services Revenue (USD Million) by Players (2018-2023)
    Table 131. Global Cell and Gene Therapy Manufacturing Services Revenue Share by Players (2018-2023)
    Table 132. Breakdown of Cell and Gene Therapy Manufacturing Services by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 133. Market Position of Players in Cell and Gene Therapy Manufacturing Services, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 134. Head Office of Key Cell and Gene Therapy Manufacturing Services Players
    Table 135. Cell and Gene Therapy Manufacturing Services Market: Company Product Type Footprint
    Table 136. Cell and Gene Therapy Manufacturing Services Market: Company Product Application Footprint
    Table 137. Cell and Gene Therapy Manufacturing Services New Market Entrants and Barriers to Market Entry
    Table 138. Cell and Gene Therapy Manufacturing Services Mergers, Acquisition, Agreements, and Collaborations
    Table 139. Global Cell and Gene Therapy Manufacturing Services Consumption Value (USD Million) by Type (2018-2023)
    Table 140. Global Cell and Gene Therapy Manufacturing Services Consumption Value Share by Type (2018-2023)
    Table 141. Global Cell and Gene Therapy Manufacturing Services Consumption Value Forecast by Type (2024-2029)
    Table 142. Global Cell and Gene Therapy Manufacturing Services Consumption Value by Application (2018-2023)
    Table 143. Global Cell and Gene Therapy Manufacturing Services Consumption Value Forecast by Application (2024-2029)
    Table 144. North America Cell and Gene Therapy Manufacturing Services Consumption Value by Type (2018-2023) & (USD Million)
    Table 145. North America Cell and Gene Therapy Manufacturing Services Consumption Value by Type (2024-2029) & (USD Million)
    Table 146. North America Cell and Gene Therapy Manufacturing Services Consumption Value by Application (2018-2023) & (USD Million)
    Table 147. North America Cell and Gene Therapy Manufacturing Services Consumption Value by Application (2024-2029) & (USD Million)
    Table 148. North America Cell and Gene Therapy Manufacturing Services Consumption Value by Country (2018-2023) & (USD Million)
    Table 149. North America Cell and Gene Therapy Manufacturing Services Consumption Value by Country (2024-2029) & (USD Million)
    Table 150. Europe Cell and Gene Therapy Manufacturing Services Consumption Value by Type (2018-2023) & (USD Million)
    Table 151. Europe Cell and Gene Therapy Manufacturing Services Consumption Value by Type (2024-2029) & (USD Million)
    Table 152. Europe Cell and Gene Therapy Manufacturing Services Consumption Value by Application (2018-2023) & (USD Million)
    Table 153. Europe Cell and Gene Therapy Manufacturing Services Consumption Value by Application (2024-2029) & (USD Million)
    Table 154. Europe Cell and Gene Therapy Manufacturing Services Consumption Value by Country (2018-2023) & (USD Million)
    Table 155. Europe Cell and Gene Therapy Manufacturing Services Consumption Value by Country (2024-2029) & (USD Million)
    Table 156. Asia-Pacific Cell and Gene Therapy Manufacturing Services Consumption Value by Type (2018-2023) & (USD Million)
    Table 157. Asia-Pacific Cell and Gene Therapy Manufacturing Services Consumption Value by Type (2024-2029) & (USD Million)
    Table 158. Asia-Pacific Cell and Gene Therapy Manufacturing Services Consumption Value by Application (2018-2023) & (USD Million)
    Table 159. Asia-Pacific Cell and Gene Therapy Manufacturing Services Consumption Value by Application (2024-2029) & (USD Million)
    Table 160. Asia-Pacific Cell and Gene Therapy Manufacturing Services Consumption Value by Region (2018-2023) & (USD Million)
    Table 161. Asia-Pacific Cell and Gene Therapy Manufacturing Services Consumption Value by Region (2024-2029) & (USD Million)
    Table 162. South America Cell and Gene Therapy Manufacturing Services Consumption Value by Type (2018-2023) & (USD Million)
    Table 163. South America Cell and Gene Therapy Manufacturing Services Consumption Value by Type (2024-2029) & (USD Million)
    Table 164. South America Cell and Gene Therapy Manufacturing Services Consumption Value by Application (2018-2023) & (USD Million)
    Table 165. South America Cell and Gene Therapy Manufacturing Services Consumption Value by Application (2024-2029) & (USD Million)
    Table 166. South America Cell and Gene Therapy Manufacturing Services Consumption Value by Country (2018-2023) & (USD Million)
    Table 167. South America Cell and Gene Therapy Manufacturing Services Consumption Value by Country (2024-2029) & (USD Million)
    Table 168. Middle East & Africa Cell and Gene Therapy Manufacturing Services Consumption Value by Type (2018-2023) & (USD Million)
    Table 169. Middle East & Africa Cell and Gene Therapy Manufacturing Services Consumption Value by Type (2024-2029) & (USD Million)
    Table 170. Middle East & Africa Cell and Gene Therapy Manufacturing Services Consumption Value by Application (2018-2023) & (USD Million)
    Table 171. Middle East & Africa Cell and Gene Therapy Manufacturing Services Consumption Value by Application (2024-2029) & (USD Million)
    Table 172. Middle East & Africa Cell and Gene Therapy Manufacturing Services Consumption Value by Country (2018-2023) & (USD Million)
    Table 173. Middle East & Africa Cell and Gene Therapy Manufacturing Services Consumption Value by Country (2024-2029) & (USD Million)
    Table 174. Cell and Gene Therapy Manufacturing Services Raw Material
    Table 175. Key Suppliers of Cell and Gene Therapy Manufacturing Services Raw Materials
List of Figures
    Figure 1. Cell and Gene Therapy Manufacturing Services Picture
    Figure 2. Global Cell and Gene Therapy Manufacturing Services Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Cell and Gene Therapy Manufacturing Services Consumption Value Market Share by Type in 2022
    Figure 4. Allogeneic
    Figure 5. Autologous
    Figure 6. Viral Vector
    Figure 7. Global Cell and Gene Therapy Manufacturing Services Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 8. Cell and Gene Therapy Manufacturing Services Consumption Value Market Share by Application in 2022
    Figure 9. Oncology Diseases Picture
    Figure 10. Cardiovascular Diseases Picture
    Figure 11. Orthopedic Diseases Picture
    Figure 12. Ophthalmology Diseases Picture
    Figure 13. Infectious Diseases Picture
    Figure 14. Others Picture
    Figure 15. Global Cell and Gene Therapy Manufacturing Services Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 16. Global Cell and Gene Therapy Manufacturing Services Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 17. Global Market Cell and Gene Therapy Manufacturing Services Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 18. Global Cell and Gene Therapy Manufacturing Services Consumption Value Market Share by Region (2018-2029)
    Figure 19. Global Cell and Gene Therapy Manufacturing Services Consumption Value Market Share by Region in 2022
    Figure 20. North America Cell and Gene Therapy Manufacturing Services Consumption Value (2018-2029) & (USD Million)
    Figure 21. Europe Cell and Gene Therapy Manufacturing Services Consumption Value (2018-2029) & (USD Million)
    Figure 22. Asia-Pacific Cell and Gene Therapy Manufacturing Services Consumption Value (2018-2029) & (USD Million)
    Figure 23. South America Cell and Gene Therapy Manufacturing Services Consumption Value (2018-2029) & (USD Million)
    Figure 24. Middle East and Africa Cell and Gene Therapy Manufacturing Services Consumption Value (2018-2029) & (USD Million)
    Figure 25. Global Cell and Gene Therapy Manufacturing Services Revenue Share by Players in 2022
    Figure 26. Cell and Gene Therapy Manufacturing Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 27. Global Top 3 Players Cell and Gene Therapy Manufacturing Services Market Share in 2022
    Figure 28. Global Top 6 Players Cell and Gene Therapy Manufacturing Services Market Share in 2022
    Figure 29. Global Cell and Gene Therapy Manufacturing Services Consumption Value Share by Type (2018-2023)
    Figure 30. Global Cell and Gene Therapy Manufacturing Services Market Share Forecast by Type (2024-2029)
    Figure 31. Global Cell and Gene Therapy Manufacturing Services Consumption Value Share by Application (2018-2023)
    Figure 32. Global Cell and Gene Therapy Manufacturing Services Market Share Forecast by Application (2024-2029)
    Figure 33. North America Cell and Gene Therapy Manufacturing Services Consumption Value Market Share by Type (2018-2029)
    Figure 34. North America Cell and Gene Therapy Manufacturing Services Consumption Value Market Share by Application (2018-2029)
    Figure 35. North America Cell and Gene Therapy Manufacturing Services Consumption Value Market Share by Country (2018-2029)
    Figure 36. United States Cell and Gene Therapy Manufacturing Services Consumption Value (2018-2029) & (USD Million)
    Figure 37. Canada Cell and Gene Therapy Manufacturing Services Consumption Value (2018-2029) & (USD Million)
    Figure 38. Mexico Cell and Gene Therapy Manufacturing Services Consumption Value (2018-2029) & (USD Million)
    Figure 39. Europe Cell and Gene Therapy Manufacturing Services Consumption Value Market Share by Type (2018-2029)
    Figure 40. Europe Cell and Gene Therapy Manufacturing Services Consumption Value Market Share by Application (2018-2029)
    Figure 41. Europe Cell and Gene Therapy Manufacturing Services Consumption Value Market Share by Country (2018-2029)
    Figure 42. Germany Cell and Gene Therapy Manufacturing Services Consumption Value (2018-2029) & (USD Million)
    Figure 43. France Cell and Gene Therapy Manufacturing Services Consumption Value (2018-2029) & (USD Million)
    Figure 44. United Kingdom Cell and Gene Therapy Manufacturing Services Consumption Value (2018-2029) & (USD Million)
    Figure 45. Russia Cell and Gene Therapy Manufacturing Services Consumption Value (2018-2029) & (USD Million)
    Figure 46. Italy Cell and Gene Therapy Manufacturing Services Consumption Value (2018-2029) & (USD Million)
    Figure 47. Asia-Pacific Cell and Gene Therapy Manufacturing Services Consumption Value Market Share by Type (2018-2029)
    Figure 48. Asia-Pacific Cell and Gene Therapy Manufacturing Services Consumption Value Market Share by Application (2018-2029)
    Figure 49. Asia-Pacific Cell and Gene Therapy Manufacturing Services Consumption Value Market Share by Region (2018-2029)
    Figure 50. China Cell and Gene Therapy Manufacturing Services Consumption Value (2018-2029) & (USD Million)
    Figure 51. Japan Cell and Gene Therapy Manufacturing Services Consumption Value (2018-2029) & (USD Million)
    Figure 52. South Korea Cell and Gene Therapy Manufacturing Services Consumption Value (2018-2029) & (USD Million)
    Figure 53. India Cell and Gene Therapy Manufacturing Services Consumption Value (2018-2029) & (USD Million)
    Figure 54. Southeast Asia Cell and Gene Therapy Manufacturing Services Consumption Value (2018-2029) & (USD Million)
    Figure 55. Australia Cell and Gene Therapy Manufacturing Services Consumption Value (2018-2029) & (USD Million)
    Figure 56. South America Cell and Gene Therapy Manufacturing Services Consumption Value Market Share by Type (2018-2029)
    Figure 57. South America Cell and Gene Therapy Manufacturing Services Consumption Value Market Share by Application (2018-2029)
    Figure 58. South America Cell and Gene Therapy Manufacturing Services Consumption Value Market Share by Country (2018-2029)
    Figure 59. Brazil Cell and Gene Therapy Manufacturing Services Consumption Value (2018-2029) & (USD Million)
    Figure 60. Argentina Cell and Gene Therapy Manufacturing Services Consumption Value (2018-2029) & (USD Million)
    Figure 61. Middle East and Africa Cell and Gene Therapy Manufacturing Services Consumption Value Market Share by Type (2018-2029)
    Figure 62. Middle East and Africa Cell and Gene Therapy Manufacturing Services Consumption Value Market Share by Application (2018-2029)
    Figure 63. Middle East and Africa Cell and Gene Therapy Manufacturing Services Consumption Value Market Share by Country (2018-2029)
    Figure 64. Turkey Cell and Gene Therapy Manufacturing Services Consumption Value (2018-2029) & (USD Million)
    Figure 65. Saudi Arabia Cell and Gene Therapy Manufacturing Services Consumption Value (2018-2029) & (USD Million)
    Figure 66. UAE Cell and Gene Therapy Manufacturing Services Consumption Value (2018-2029) & (USD Million)
    Figure 67. Cell and Gene Therapy Manufacturing Services Market Drivers
    Figure 68. Cell and Gene Therapy Manufacturing Services Market Restraints
    Figure 69. Cell and Gene Therapy Manufacturing Services Market Trends
    Figure 70. Porters Five Forces Analysis
    Figure 71. Manufacturing Cost Structure Analysis of Cell and Gene Therapy Manufacturing Services in 2022
    Figure 72. Manufacturing Process Analysis of Cell and Gene Therapy Manufacturing Services
    Figure 73. Cell and Gene Therapy Manufacturing Services Industrial Chain
    Figure 74. Methodology
    Figure 75. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Thermo Fisher Scientific
Merck KGaA
Charles River Laboratories
Lonza
Catalent
WuXi AppTec
Takara Bio Inc
Nikon Corporation
FUJIFILM Holdings Corporation
F. Hoffmann-La Roche
Oxford Biomedica Plc
Cell and Gene Therapy Catapult
The Discovery Labs LLC
RoslinCT
JRS PHARMA
FinVector
ABL
Resilience
BioCentriq
Porton Biopharma Limited
Andelyn Biosciences
Commercializing Living Therapies
Vibalogics
Anemocyte Srl
ElevateBio

Related Reports

Global Cell and Gene Therapy Manufacturing Services Supply, Demand and Key Producers, 2023-2029

Global Cell and Gene Therapy Manufacturing Services Supply, Demand and Key Producers, 2023-2029

date 05 Feb 2023

date Medical Devices & Consumables

The global Cell and Gene Therapy Manufacturing Services market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Cell and Gene Therapy Manufacturing Services Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Cell and Gene Therapy Manufacturing Services Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 21 Jan 2024

date Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Cell and Gene Therapy Manufacturing Services market size was valued at USD 4866.7 million in 2023 and is forecast to a readjusted size of USD 8624.4 million by 2030 with a CAGR of 8.5% during review period.

Product Tags

Cell and Gene Therapy Manufacturing Services

Blood Plasma Refrigerator

ENT Camera System

Medical Repair Titanium Mesh

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>